Marcello Agosti | Takeda Pharmaceuticals
Marcello Agosti is the global business development officer for Takeda and is responsible for Takeda’s business development activities, including M&A and Corporate Development.
Marcello led the Shire acquisition and several other strategic acquisitions for Takeda, including ARIAD Pharmaceuticals and TiGenix as well asset acquisitions such as TAK-279 from Nimbus Therapeutics and fruquintinib from HUTCHMED. He also spearheaded a number of strategic divestments of non-core assets as part of Takeda’s commitment after the Shire acquisition. Marcello and his group continue to be active on inbound transactions in Takeda’s core therapy areas.
Prior to joining Takeda, Marcello worked in business development at Novartis in the U.K. and Switzerland. Before joining the pharmaceutical industry, he was a consultant at McKinsey & Company.
He holds an MBA from the University of Oxford and a business administration degree from Bocconi University, Milan.
Marcello is based in Boston.